Sanguinity Trading Company Profile
Key Indicators
- Authorised Capital ₹ 1.10 M
- Paid Up Capital ₹ 1.00 M
- Company Age 18 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 215.64%
- Profit Growth 773.61%
- Ebitda 51.40%
- Net Worth 17.88%
- Total Assets -11.42%
About Sanguinity Trading Company
Sanguinity Trading Company Private Limited (STCPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 November 2006 and has a history of 18 years and two months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Metals And Minerals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.10 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ashutosh Taparia, Mahesh Ladha, Sunil Kedia, and Three other members serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909MH2006PTC165687
-
Company No.
165687
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Nov 2006
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Sanguinity Trading Company?
Board Members (6)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ashutosh Taparia | Director | 27-Dec-2006 | Current |
Mahesh Ladha | Director | 26-Sep-2019 | Current |
Sunil Kedia | Director | 04-Jan-2020 | Current |
Pranav Singi | Director | 17-Sep-2020 | Current |
Sanjeevkumar Taparia | Director | 27-Dec-2006 | Current |
Jyotiprasad Taparia | Director | 10-Apr-2007 | Current |
Financial Performance of Sanguinity Trading Company.
Sanguinity Trading Company Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 215.64% increase. The company also saw a substantial improvement in profitability, with a 773.61% increase in profit. The company's net worth Soared by an impressive increase of 17.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Sanguinity Trading Company?
In 2022, Sanguinity Trading Company had a public holding of 4.26%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sanguinity Trading Company?
Unlock and access historical data on people associated with Sanguinity Trading Company, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanguinity Trading Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanguinity Trading Company's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.